←
Movement Disorders Clinical Practice1,074 posts
Movement Disorders Clinical Practice avatar

Movement Disorders Clinical Practice

@MDCP_Journal

Movement Disorders Clinical Practice is the exclusively online Journal of the International Parkinson and Movement Disorder Society (MDS) @movedisorder.

◷ Joined November 2018▧ 281 Photos and videos
Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Nov 17

The eyes may tell you which ataxia your patient has. This outstanding practical review reminds us that specific oculomotor findings can be powerful diagnostic clues: -Slow saccades → think SCA2 -Vertical supranuclear gaze palsy → think Niemann-Pick type C -Bilateral VOR loss → think CANVAS -"Bulging eyes" (pseudoproptosis) → think SCA3 Before the genetic report arrives, the bedside eye movement exam may already be pointing you in the right direction. loom.ly/emizyAs

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Nov 12

A positive α-synuclein test is not a Parkinson's diagnosis. But it can change a life. This important paper explores the ethical challenge of prodromal PD: how do we discuss biomarkers, RBD and future disease risk without creating anxiety, stigma and loss of identity? As biomarkers improve, communication skills may become just as important as diagnostic accuracy. loom.ly/Pm3-zos

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Nov 9

"My legs shake when I stand." Are you sure it's tremor? Key message: if the history is "shaky legs + unsteadiness on standing", don't assume orthostatic tremor. It could be Orthostatic Myoclonus! Surface EMG is essential to accurate diagnosis. In this cohort: -79% had an underlying neurological disorder -26% had parkinsonism -Nearly all had gait instability loom.ly/WpnNiBk

Post attachment
Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Nov 2

Fragility fracture in Parkinson’s? Treat the bone, not just the fall. In this large UK study, only 38% of patients with parkinsonism received bone-protective medication within 16 weeks of a fragility fracture, and just 53% by 48 weeks. Men and patients with rib fractures were particularly likely to miss treatment. Bone health belongs in the movement disorders clinic! loom.ly/CN43aPU

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 30

BoNT works for cervical dystonia. The problem? It may not last until the next injection. Could rTMS bridge the gap? In the D-TWIST pilot, accelerated rTMS was safe, feasible and well tolerated, with an encouraging but preliminary signal for symptom improvement. A fascinating adjunctive strategy, now needing a properly powered trial. loom.ly/auZpT0U

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 28

Handwriting in Parkinson’s is about much more than size. Digital analysis showed that de novo PD was characterised by slower writing, reduced acceleration and more in-air time, while acute inhaled levodopa shortened both in-air and on-surface writing time. The pen may provide an objective window into bradykinesia, treatment response and disease progression. loom.ly/UU3ViUc

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 26

Could essential tremor become a wearable-treated disorder? An AI-driven wristband delivering peripheral nerve stimulation was associated with sustained functional improvement over 1 year, with mADL benefit increasing from 6.9 points at 90 days to 9.7 at 1 year. Encouraging non-invasive neuromodulation data, but the open-label extension and attrition warrant caution. loom.ly/0JB22xY

Post attachment
Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 23

“Cerebral palsy” that is getting worse? Think again. Early-onset hereditary spastic paraplegia (HSP) is an under-recognised mimic of CP, particularly when there is: -Progressive spastic gait -Loss of previously acquired motor skills -True weakness -Knee recurvatum -Dystonia or parkinsonism No family history does not exclude HSP. Early genetic testing can be key, especially as mechanism-targeted therapies begin to emerge. loom.ly/akigKf0

Post attachment
Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 21

Want to learn DBS microelectrode recording? Start listening. This superb educational resource teaches the characteristic MER recordings encountered along Vim, STN and GPi trajectories, combining narrated audiovisual examples with Anki flashcards for self-testing. loom.ly/AkhczPM

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 19

Not every request for rescue levodopa represents motor OFF. In refractory DDS, severe anxiety accompanied self-perceived OFF states and drove escalating dopaminergic use. Pregabalin was followed by resolution of rescue levodopa use and a substantial reduction in LEDD. Before escalating dopamine, distinguish objective motor OFF from affective distress and medication craving. movementdisorders.onlinelibr…

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 14

Is adaptive DBS really better than conventional DBS? Not yet, at least with this beta-guided dual-threshold approach. In a blinded randomized crossover pilot, aDBS and cDBS had comparable clinical efficacy, with substantial patient-to-patient variability. The future of aDBS may lie in personalization, not simply adaptation. loom.ly/giug0fw

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 12

Expertise exists. Access doesn’t always follow. Across Latin America, children with movement disorders face highly variable access to genetic testing, imaging, DBS, medications and emerging targeted therapies. This viewpoint proposes a powerful solution: regional networks + shared education + collaborative research + locally adapted care pathways. loom.ly/U9xicg0

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Oct 7

Same UPDRS improvement. Different motor physiology? Both L-dopa and STN-DBS improved finger-tapping scores in PD, but kinematics told a more interesting story: -L-dopa → fewer hesitations -STN-DBS → fewer interruptions -Sequence effect → improved by neither Bradykinesia is a complex, not a single deficit. loom.ly/1dl5nk8

Movement Disorders Clinical Practice avatar
Movement Disorders Clinical Practice@MDCP_Journal·Sep 30

Your patient is motorically ON. But are they neuropsychiatrically ON? This excellent review reframes neuropsychiatric fluctuations in PD as dynamic, dopamine-linked phenomena that may precede, exceed or occur independently of motor fluctuations. -OFF: anxiety, apathy, low mood, fatigue, cognitive slowing -ON: increased drive, impulsivity, disinhibition, hyperactivity Don’t just ask “When do you wear OFF?” Ask how mood, thinking and behaviour change around each levodopa dose. loom.ly/Ow7EwZI

Post attachment